Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication class of statins.
Pitavastatin is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.
It was patented in 1987 and approved for medical use in 2003. It is available in Japan, South Korea and in India. In the US, it received FDA approval in 2009.
Kowa Pharmaceuticals, a subsidiary of Kowa Company, is the owner of the American patent to pitavastatin. |
Read full article at Wikipedia
|
InChI=1S/C25H25N5O4/c1- 34- 19- 11- 9- 18(10- 12- 19) 30- 23- 20(22(27- 30) 24(26) 32) 13- 15- 29(25(23) 33) 17- 7- 5- 16(6- 8- 17) 28- 14- 3- 2- 4- 21(28) 31/h5- 12H,2- 4,13- 15H2,1H3,(H2,26,32) |
QNZCBYKSOIHPEH-UHFFFAOYSA-N |
COc1ccc(cc1)-n1nc(C(N)=O)c2CCN(C(=O)c12)c1ccc(cc1)N1CCCCC1=O |
|
EC 3.4.21.6 (coagulation factor Xa) inhibitor
An EC 3.4.21.* (serine endopeptidase) inhibitor that interferes with the action of coagulation factor Xa (EC 3.4.21.6).
|
|
anticoagulant
An agent that prevents blood clotting.
|
|
View more via ChEBI Ontology
1- (4- methoxyphenyl)- 7- oxo- 6- [4- (2- oxopiperidin- 1- yl)phenyl]- 4,5,6,7- tetrahydro- 1H- pyrazolo[3,4- c]pyridine- 3- carboxamide
|
apixaban
|
WHO MedNet
|
apixabán
|
WHO MedNet
|
apixaban
|
KEGG DRUG
|
apixabanum
|
WHO MedNet
|
BMS 562247-01
|
ChemIDplus
|
BMS-562247
|
DrugBank
|
BMS-562247-01
|
ChemIDplus
|
11244786
|
Reaxys Registry Number
|
Reaxys
|
503612-47-3
|
CAS Registry Number
|
ChemIDplus
|
503612-47-3
|
CAS Registry Number
|
KEGG DRUG
|
|